AKT1 and Parkinson disease: In a previous study, differentiated SHSY5Y cells underwent some alteration in the AKT pathway, and had higher tolerance to the toxicity of 6OHDA [35], meaning that undifferentiated SHSY5Y cells may be more suitable for a Parkinson’s disease model.